ArticleHaematologica2024

Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

Yuta Kaito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.